Wednesday, December 16, 2015

FDA Approves Alecensa (Alectinib) for Non-Small Cell Lung Cancer

… with advanced ALK-positive non-small cell lung cancer (NSCLC) that has become worse …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)